Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Wuxi Taxus Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Allopurinol

    02 1L5-Methyltetrahydrofolate Calcium

    03 1Paclitaxel

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Allopurinol

      Product
      Web Link

      Stock Recap
      #PipelineProspector

      Market
      Place

      The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
      The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.
      blank

      01

      Allopurinol

      China
      2024 ACI Convention
      Not Confirmed
      arrow

      Allopurinol

      China
      arrow
      2024 ACI Convention
      Not Confirmed
      • fda
      • EDQM
      • WHO-GMP
      Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Wuxi Taxus Pharmaceutical

      The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.

      About the Company : The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to tr...

      blank

      Product
      Web Link

      Stock Recap
      #Pipeline Prospector

      Market
      Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        L5-Methyltetrahydrofolate Calcium

        Product
        Web Link

        Stock Recap
        #PipelineProspector

        Market
        Place

        The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
        The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.
        blank

        02

        L5-Methyltetrahydrofolate Calcium

        China
        2024 ACI Convention
        Not Confirmed
        arrow

        L5-Methyltetrahydrofolate Calcium

        China
        arrow
        2024 ACI Convention
        Not Confirmed
        • fda
        • EDQM
        • WHO-GMP
        Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        Wuxi Taxus Pharmaceutical

        The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.

        About the Company : The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to tr...

        blank

        Product
        Web Link

        Stock Recap
        #Pipeline Prospector

        Market
        Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Paclitaxel

          Product
          Web Link

          Stock Recap
          #PipelineProspector

          Market
          Place

          The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw m...
          The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.
          blank

          03

          Paclitaxel

          China
          2024 ACI Convention
          Not Confirmed
          arrow

          Paclitaxel

          China
          arrow
          2024 ACI Convention
          Not Confirmed
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Post an Enquiry Post an Enquiry
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          Wuxi Taxus Pharmaceutical

          The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to transform and upgrade and optimize the development of the industrial structure. It is mainly engaged in taxanes. R&D, production and sales of anti-tumor raw materials and preparations. At present, the industrial chain of yew resource cultivation, yew branch and leaf processing, paclitaxel raw material preliminary product, paclitaxel injection and other anti-tumor drug preparations has been formed.

          About the Company : The company was established in February 2006. It is a pharmaceutical company that belongs to the Hongdou Group's yew health field. It is a strategic emerging industry for the Hongdou Group to tr...

          blank

          Product
          Web Link

          Stock Recap
          #Pipeline Prospector

          Market
          Place

          Contact Wuxi Taxus Pharmaceutical and get a quotation

          Wuxi Taxus Pharmaceutical is a supplier offers 4 products (APIs, Excipients or Intermediates).

          Find a price of 10-Deacetylbaccatin- III bulk with DMF offered by Wuxi Taxus Pharmaceutical

          Find a price of Allopurinol bulk offered by Wuxi Taxus Pharmaceutical

          Find a price of Levomefolate Calcium bulk offered by Wuxi Taxus Pharmaceutical

          Find a price of Paclitaxel bulk offered by Wuxi Taxus Pharmaceutical